Royalty Change To Inventory from 2010 to 2025

RPRX Stock  USD 33.64  0.27  0.81%   
Royalty Pharma Change To Inventory yearly trend continues to be fairly stable with very little volatility. Change To Inventory will likely drop to about -38.3 M in 2025. Change To Inventory is the increase or decrease in the amount of inventory Royalty Pharma Plc has over a certain period. View All Fundamentals
 
Change To Inventory  
First Reported
2010-12-31
Previous Quarter
-36.5 M
Current Value
-38.3 M
Quarterly Volatility
79 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Royalty Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Royalty Pharma's main balance sheet or income statement drivers, such as Interest Expense of 237.3 M, Total Revenue of 2.4 B or Research Development of 1.9 M, as well as many indicators such as Price To Sales Ratio of 4.79, Dividend Yield of 0.0362 or PTB Ratio of 1.05. Royalty financial statements analysis is a perfect complement when working with Royalty Pharma Valuation or Volatility modules.
  
Check out the analysis of Royalty Pharma Correlation against competitors.

Latest Royalty Pharma's Change To Inventory Growth Pattern

Below is the plot of the Change To Inventory of Royalty Pharma Plc over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Royalty Pharma's Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Royalty Pharma's overall financial position and show how it may be relating to other accounts over time.
Change To Inventory10 Years Trend
Slightly volatile
   Change To Inventory   
       Timeline  

Royalty Change To Inventory Regression Statistics

Arithmetic Mean(100,359,190)
Coefficient Of Variation(78.70)
Mean Deviation74,247,536
Median(166,357,000)
Standard Deviation78,984,154
Sample Variance6238.5T
Range195.5M
R-Value0.53
Mean Square Error4788.5T
R-Squared0.28
Significance0.03
Slope8,834,894
Total Sum of Squares93577.4T

Royalty Change To Inventory History

2025-38.3 M
2024-36.5 M
2022-31.7 M
202129.1 M
2020400 K
2011-166.4 M
2010108 K

About Royalty Pharma Financial Statements

Royalty Pharma investors use historical fundamental indicators, such as Royalty Pharma's Change To Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Royalty Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Inventory-36.5 M-38.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Royalty Stock Analysis

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.